140613-57-6Relevant articles and documents
BIOINK GEL FORMULATIONS COMPRISING NUCLEOLIPID-BASED COMPOUND
-
Page/Page column 15; 18; 19, (2019/07/17)
The present invention relates to nucleolipid-based compounds for use in regenerative medicine. More specifically, the invention relates to the use of to nucleolipid-based compounds in bioink gel formulations and a bioprinting method comprising the use of
Oligonucleotide with protected base
-
Page/Page column 74, (2016/07/27)
The present invention provides a protected nucleotide for elongation, which can be purified efficiently and in a high yield by a liquid-liquid extraction operation, and can achieve an oligonucleotide production method by a phosphoramidite method. It has been found that the above-mentioned problem can be solved by a particular oligonucleotide comprising a protected base and/or particular oligonucleotide protected by a branched chain-containing aromatic group at 3′-position.
OLIGONUCLEOTIDE WITH PROTECTED BASE
-
Page/Page column, (2013/10/22)
The present invention provides a protected nucleotide for elongation, which can be purified efficiently and in a high yield by a liquid-liquid extraction operation, and can achieve an oligonucleotide production method by a phosphoramidite method. It has been found that the above-mentioned problem can be solved by a particular oligonucleotide comprising a protected base and/or particular oligonucleotide protected by a branched chain-containing aromatic group at 3′-position.